Abstract

PT16 Impact of Data Maturity on the Estimation of the within-Trial Hazard Function: An Example from Metastatic Castration Resistant Prostate Cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
Liancheng Fan ... Xiaochen Fei
Investigative urology | VOL. 205
Liancheng Fan, et. al.Liancheng Fan ... Xiaochen Fei
08 Sep 2020
Second-line treatment options in metastatic castration-resistant prostate cancer: A comparison of key trials with recently approved agents
Amit Bahl ... Johann De Bono
Evidence-based Oncology | VOL. 40
Amit Bahl, et. al.Amit Bahl ... Johann De Bono
16 Aug 2013
Phase 3 VERACITY clinical study of sabizabulin in men with metastatic castrate resistant prostate cancer who have progressed on an androgen receptor targeting agent.
Robert Dreicer ... Robert H Getzenberg
Journal of Clinical Oncology | VOL. 40
Robert Dreicer, et. al.Robert Dreicer ... Robert H Getzenberg
20 Feb 2022
Novel quantitative software for automatically excluding red bone marrow on whole-body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study.
Yuki Kohada ... Jun Ito
International journal of urology : official journal of the Japanese Urological Association | VOL. 30
Yuki Kohada, et. al.Yuki Kohada ... Jun Ito
20 Dec 2022
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
How many Monte Carlo samples are needed for probabilistic cost-effectiveness analyses?
Reza Yaesoubi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Reza YaesoubiReza Yaesoubi
06 Jul 2024
Three Pillars of Support for Orphan Drug Programs: Individual Valuations, Societal Valuations, and Anonymous Altruism
Darius N Lakdawalla ... Hong-Hanh Nguyen
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Darius N Lakdawalla, et. al.Darius N Lakdawalla ... Hong-Hanh Nguyen
06 Jul 2024
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Methods for measuring and valuing informal care: A systematic review and meta-analysis in stroke
Neha Das ... Lan Gao
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Neha Das, et. al.Neha Das ... Lan Gao
06 Jul 2024
View more papers